Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C3H5NS |
| Molecular Weight | 87.144 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN=C=S
InChI
InChIKey=HBNYJWAFDZLWRS-UHFFFAOYSA-N
InChI=1S/C3H5NS/c1-2-4-3-5/h2H2,1H3
| Molecular Formula | C3H5NS |
| Molecular Weight | 87.144 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Diphosphanylketenimines: new reagents for the synthesis of unique phosphorus heterocycles. | 2002 Sep 2 |
|
| Paradoxical effect of synthetic hydroxy isothiocyanates on antimicrobial action of aminoglycosides. | 2003 Aug |
|
| Cyclization reactions of acylium and thioacylium ions with isocyanates and isothiocyanates: gas phase synthesis of 3,4-dihydro-2,4-dioxo-2H-1,3,5-oxadiazinium ions. | 2005 Oct |
|
| Sensitisation for cisplatin-induced apoptosis by isothiocyanate E-4IB leads to signalling pathways alterations. | 2006 Nov 20 |
|
| Conformational stability, structural parameters and vibrational assignment from variable temperature infrared spectra of krypton solutions and ab initio calculations of ethylisothiocyanate. | 2007 Nov |
|
| Synthesis and structural investigation of mono- and polynuclear copper complexes of 4-ethyl-1-(pyridin-2-yl) thiosemicarbazide. | 2008 Nov 1 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 06:48:51 GMT 2023
by
admin
on
Sat Dec 16 06:48:51 GMT 2023
|
| Record UNII |
3284MJ2T8P
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
3284MJ2T8P
Created by
admin on Sat Dec 16 06:48:51 GMT 2023 , Edited by admin on Sat Dec 16 06:48:51 GMT 2023
|
PRIMARY | |||
|
84212
Created by
admin on Sat Dec 16 06:48:51 GMT 2023 , Edited by admin on Sat Dec 16 06:48:51 GMT 2023
|
PRIMARY | |||
|
C039155
Created by
admin on Sat Dec 16 06:48:51 GMT 2023 , Edited by admin on Sat Dec 16 06:48:51 GMT 2023
|
PRIMARY | |||
|
208-831-2
Created by
admin on Sat Dec 16 06:48:51 GMT 2023 , Edited by admin on Sat Dec 16 06:48:51 GMT 2023
|
PRIMARY | |||
|
1863
Created by
admin on Sat Dec 16 06:48:51 GMT 2023 , Edited by admin on Sat Dec 16 06:48:51 GMT 2023
|
PRIMARY | |||
|
10966
Created by
admin on Sat Dec 16 06:48:51 GMT 2023 , Edited by admin on Sat Dec 16 06:48:51 GMT 2023
|
PRIMARY | |||
|
85098
Created by
admin on Sat Dec 16 06:48:51 GMT 2023 , Edited by admin on Sat Dec 16 06:48:51 GMT 2023
|
PRIMARY | |||
|
m5140
Created by
admin on Sat Dec 16 06:48:51 GMT 2023 , Edited by admin on Sat Dec 16 06:48:51 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID2060258
Created by
admin on Sat Dec 16 06:48:51 GMT 2023 , Edited by admin on Sat Dec 16 06:48:51 GMT 2023
|
PRIMARY | |||
|
542-85-8
Created by
admin on Sat Dec 16 06:48:51 GMT 2023 , Edited by admin on Sat Dec 16 06:48:51 GMT 2023
|
PRIMARY |